Overview

Daylight Photodynamic Therapy for Actinic Keratosis and Skin Field Cancerization

Status:
Unknown status
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
Twenty patients with multiple actinic keratosis on the face will be enrolled in the study and will be treated with Daylight Photodynamic therapy. Before and after skin biopsies will be performed, for histological and immunohistochemical analysis.
Phase:
N/A
Details
Lead Sponsor:
University of Sao Paulo General Hospital
Treatments:
Aminolevulinic Acid
Methyl 5-aminolevulinate